Xiao‐Shun He

1.1k total citations
29 papers, 681 citations indexed

About

Xiao‐Shun He is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiao‐Shun He has authored 29 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Xiao‐Shun He's work include Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and Ubiquitin and proteasome pathways (4 papers). Xiao‐Shun He is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and Ubiquitin and proteasome pathways (4 papers). Xiao‐Shun He collaborates with scholars based in China, United States and Germany. Xiao‐Shun He's co-authors include Hua Wu, Jianming Li, Ian R. Corbin, Rohit S. Mulik, Wen-Juan Gan, Jeffrey G. McDonald, Weijun Ou, Jingru Wang, Xiu‐Ming Li and Peng-Da Guo and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

Xiao‐Shun He

26 papers receiving 679 citations

Peers

Xiao‐Shun He

PRM

IMMUN

ONCOL

Shucai Yang China

Shilei Tang China

Chloe Shay United States

Xiaohui Pan China

Heba Alshaker United Kingdom

Shangke Huang China

Hyeok-Gu Kang South Korea

Kateryna Shostak Belgium

Yingke Liang China

Longzhen Piao China

Shucai Yang China

Xiao‐Shun He

509 ×1.3

317 ×1.3

95 ×0.6

PRM

154 ×1.1

IMMUN

230 ×1.8

ONCOL

Citations per year, relative to Xiao‐Shun He Xiao‐Shun He (= 1×) peers Shucai Yang

Countries citing papers authored by Xiao‐Shun He

Since Specialization

Citations

This map shows the geographic impact of Xiao‐Shun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Shun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Shun He more than expected).

Fields of papers citing papers by Xiao‐Shun He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Shun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Shun He. The network helps show where Xiao‐Shun He may publish in the future.

Co-authorship network of co-authors of Xiao‐Shun He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Shun He. A scholar is included among the top collaborators of Xiao‐Shun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Shun He. Xiao‐Shun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Ning, et al.. (2025). EZH1 deficiency promotes ferroptosis resistance by activating NRF2 in sepsis-associated liver injury. Clinical Epigenetics. 17(1). 96–96. 1 indexed citations

Zhang, Mingxi, et al.. (2025). The adverse impact of early postoperative complications after liver transplantation on long-term prognosis in patients with hepatocellular carcinoma. World Journal of Surgical Oncology. 23(1). 308–308.

Wan, Shan, Xin Guo, Xiuming Li, et al.. (2024). SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma. Cancer Research. 84(11). 1872–1888. 21 indexed citations

Wan, Dong, Si Chen, Huafei Chen, et al.. (2024). Case report: Germline CHEK2 mutation is associated with a giant cell glioblastoma. Frontiers in Oncology. 14. 1361928–1361928.

Xu, Jinghong, Di Liu, Qi Zhang, et al.. (2024). Suppression of Hepatocyte Ferroptosis via USP19‐Mediated Deubiquitination of SLC7A11 in Ischemia‐Free Liver Transplantation. Advanced Science. 12(6). e2406200–e2406200. 3 indexed citations

Liu, Yuxuan, Shan Wan, Xiaoqin Yang, et al.. (2023). TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2. Cell chemical biology. 30(7). 709–725.e6. 24 indexed citations

He, Xiao‐Shun, Xiaoqin Yang, Feng Liu, et al.. (2022). Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling. Oncogene. 41(8). 1166–1177. 14 indexed citations

He, Xiao‐Shun, Jialu Yao, Zhiyong Deng, et al.. (2021). Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer. Frontiers in Molecular Biosciences. 8. 763652–763652. 7 indexed citations

Li, Jingjing, Yan Li, Xiao‐Shun He, & Qiang Zhao. (2021). Gain of GAS5 reveals worse prognosis in kidney renal clear cell carcinoma and liver hepatocellular carcinoma from the Cancer Genome Atlas dataset. Translational Cancer Research. 10(1). 223–232. 6 indexed citations

10.

Li, Qiang, Qiang Zhao, Chuanzhao Zhang, et al.. (2018). The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice. Journal of Physiology and Biochemistry. 74(2). 247–260. 16 indexed citations

11.

Li, Xiu‐Ming, Jingru Wang, Tong Shen, et al.. (2017). Nur77 deficiency in mice accelerates tumor invasion and metastasis by facilitating TNFα secretion and lowering CSF-1R expression. PLoS ONE. 12(2). e0171347–e0171347. 5 indexed citations

12.

Ou, Weijun, et al.. (2017). Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma. Free Radical Biology and Medicine. 112. 597–607. 142 indexed citations

13.

Guo, Peng-Da, Xing-Xing Lu, Wen-Juan Gan, et al.. (2016). RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo–Yap Pathway. Cancer Research. 76(13). 3813–3825. 48 indexed citations

14.

Gu, Guangxiang, Yingjuan Huang, Chenglin Wu, et al.. (2016). Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection. Transplantation. 101(1). 83–91. 13 indexed citations

15.

Li, Xiuming, Shen Zhang, Xiao‐Shun He, et al.. (2016). Nur77-mediated TRAF6 signalling protects against LPS-induced sepsis in mice. Journal of Inflammation. 13(1). 4–4. 23 indexed citations

16.

Gan, Wen-Juan, Jingru Wang, Xiao‐Shun He, et al.. (2016). RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis. Journal of Experimental & Clinical Cancer Research. 35(1). 164–164. 24 indexed citations

17.

Wu, Hua, Xiu‐Ming Li, Jingru Wang, et al.. (2015). NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR–IL‐1R signalling axis. The Journal of Pathology. 238(3). 457–469. 70 indexed citations

18.

Zhang, Peng, Xiao‐Feng Zhu, Ying Wu, et al.. (2015). Histone deacetylase inhibitors reduce WB-F344 oval cell viability and migration capability by suppressing AKT/mTOR signaling in vitro. Archives of Biochemistry and Biophysics. 590. 1–9. 4 indexed citations

19.

Zhou, Qun, Xiao‐Shun He, L. M. Song, et al.. (2015). Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection. Oncotarget. 7(4). 4981–4992. 8 indexed citations

20.

Shen, Tong, et al.. (2013). Molecular cloning, organization, expression and 3D structural analysis of the MHC class Ia gene in the whitespotted bamboo shark (Chiloscyllium plagiosum). Veterinary Immunology and Immunopathology. 157(1-2). 111–118. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact